Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

• Status: Withdrawn
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if glucose peaks higher and earlier after a meal when a patient is given intranasal insulin instead of conventional insulin treatment.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: CPEX Pharmaceuticals Inc.
• Treatments: Insulin; Insulin Aspart; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Diagnosis of Type 1 Diabetes

• Age 18-50

• Treatment management of MDI(multiple daily injections) or Insulin Pump

• BMI between 19-30 Kg/M2

• HbA1c less than or equal to 8.0%

• 75 g OGTT (oral glucose tolerance test)study with insulin concentrations >80uU/mL

Exclusion Criteria:

• Active Proliferative Retinopathy

• Active Nephropathy

• Chronic Upper Respiratory Conditions determined by MD

• Pregnant or Lactating Female